CSHL and Range ETFs Launch New Partnership
November 22, 2024
November 22, 2024
COLD SPRING HARBOR, New York, Nov. 22 (TNSres) -- The Cold Spring Harbor Laboratory issued the following news:
More than two million new cases of cancer will be diagnosed in the United States in 2024, according to the National Cancer Institute. Range Cancer Therapeutics ETF (Nasdaq: CNCR) is partnering with Cold Spring Harbor Laboratory (CSHL) to highlight CSHL's pioneering role in advancing cancer research. Through the partnership, 23% of revenues generated by fees from CNCR will b . . .
More than two million new cases of cancer will be diagnosed in the United States in 2024, according to the National Cancer Institute. Range Cancer Therapeutics ETF (Nasdaq: CNCR) is partnering with Cold Spring Harbor Laboratory (CSHL) to highlight CSHL's pioneering role in advancing cancer research. Through the partnership, 23% of revenues generated by fees from CNCR will b . . .